|
ABSTRACT
- Most people are unaware that a biological attack already has occurred in the U.S.
- In the Fall of 2001, after 9/11, four letters containing anthrax spores were mailed through the USPS to government and media locations
- The outcome was 22 confirmed cases of anthrax, 5 people dead, 23 contaminated USPS facilities, 1.8 million pieces of contaminated mail, and $14
million to clean up the Hart Senate Office building
- And this was only four letters!
- The facts are clear: bioterrorism is very dangerous and a significant threat to U.S. national security
- Certainly the U.S. government thinks so, and is taking all measures necessary to protect both its citizens and armed forces from this danger
- This report is meant to serve two purposes: provide an overview of bioterrorism defense markets, and assess opportunities and security threats
Scope of Coverage
- Specifically, the report looks at the following:
- An overview of the bioterrorism products and services markets in terms of size and growth rates between 2003 and 2008
- A look at bioterrorism' s history, who poses a threat, why the threat is growing, bioterrorism agents, agents of the highest concern,
governement agencies involved, types of response, and FAQs for a biological attack
- An analysis of the Department of Homeland Security, the U.S. government agency leading the charge against bioterrorism
- What the Department of Health and Human Services is doing in the fight on bioterrorism
- Who are first responders and what role do they play in fighting bioterrorism
- What is the best strategy for biodefense
- What are the latest products and projects in biodetection technology, and how big is the market by application for biodetection technology
- How big is the market by product type for civilian and military bioterrorism respirators
- How big is the market by product type for civilian and military bioterrorism protective clothing
- What role do vaccines and antibodies play in the war on bioterrorism, and how big is the market for smallpox and anthrax vaccines and antibodies
now and in the future.
Market Size
Demand for bioterrorism defense products and services is estimated at $4.8 billion in 2003
- 75% of the current bioterrorism market is accounted for by the activities of the Department of Health and Human Services
- And 5.6% by the Department of Homeland Security and other government agencies
- While the remaining 19% is vaccines, biodetection equipment, protective clothing, and respirators
- Demand for bioterrorism equipment and services is forecast to grow 16% annually, reaching $10 billion in 2008
- Vaccines will be the fastest growing market segment in this period, rising 54% annually, from $286 million in 2003 to $2.5 billion in 2008
- The second fastest growing market segment will be biodetection equipment, where sales will grow from $345 million in 2003 to $1.9 billion in
2008, equal to a 41% average annual growth rate
- As a result of their high growth rates, vaccines and biodetection equipment will become the largest market segments behind the Department of HHS
by 2008.
Producers
- The largest private sector producer of bioterrorism defense products is thought to be Acambis, the supplier of smallpox vaccine to the U.S.
Government
- Number two is Tex-Shield, the supplier of JSLIST suits to the U.S. military
- And third, ILC Dover, the producer of M-40 gas masks to the military
- By 2004, company shares are expected to increase
- For example, Northrop Grumman will book $175 million on its USPO contract, and Human Genome Sciences probably will sell $300 million worth of
anthrax vaccine to the government.
|
Related Report
|
View Cart
